Chris Shaw

King’s College London - Maurice Wohl Clinical Neuroscience Institute

Strand

London, England WC2R 2LS

United Kingdom

SCHOLARLY PAPERS

2

DOWNLOADS

72

SSRN CITATIONS

3

CROSSREF CITATIONS

1

Scholarly Papers (2)

1.

Rare Variant Burden Analysis within Enhancers Identifies CAV1 as a New ALS Risk Gene

Number of pages: 38 Posted: 11 Jun 2020
University of Sheffield - Sheffield Institute for Translational Neuroscience (SITraN), Stanford University - Stanford Center for Genomics and Personalized Medicine, University of Massachusetts Worcester - Department of Neurology, University of Sheffield - Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield - Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield - Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield - Sheffield Institute for Translational Neuroscience (SITraN), Weizmann Institute of Science - Department of Molecular Genetics, Weizmann Institute of Science - Department of Molecular Genetics, Weizmann Institute of Science - Department of Molecular Genetics, Lund University - Department of Biology, University of Sheffield - Sheffield Institute for Nucleic Acids (SInFoNiA), University of Sheffield - Sheffield Institute for Nucleic Acids (SInFoNiA), Massachusetts General Hospital and Harvard Medical School - Analytic and Translational Genetics Unit, Weizmann Institute of Science - Department of Molecular Genetics, Weizmann Institute of Science - Department of Molecular Genetics, University of Southampton - Faculty of Medicine, Health and Life Sciences, King’s College London - Maurice Wohl Clinical Neuroscience Institute, King’s College London - Institute of Psychiatry, Psychology and Neuroscience, Independent, Utrecht University - Department of Neurology, University of Sheffield - Sheffield Institute for Translational Neuroscience (SITraN), Stanford University - Stanford Center for Genomics and Personalized Medicine and University of Sheffield - Sheffield Institute for Translational Neuroscience (SITraN)
Downloads 36 (650,106)
Citation 1

Abstract:

Loading...

Amyotrophic lateral sclerosis, whole genome sequencing, CAV1, CAV2, noncoding DNA

2.

Mutations in the Sphingolipid Pathway Gene SPTLC1 are a Cause of Amyotrophic Lateral Sclerosis

Number of pages: 85 Posted: 06 Jun 2019
National Institutes of Health - Neuromuscular Diseases Research Section, National Institutes of Health - Neuromuscular Diseases Research Section, Government of the United States of America - National Institutes of Health (NIH), King’s College London - Maurice Wohl Clinical Neuroscience Institute, National Institutes of Health - Neuromuscular Diseases Research Section, National Institutes of Health - Molecular Genetics Section, National Institutes of Health - Neuromuscular Diseases Research Section, United Kingdom Dementia Research Institute Centre, National Institutes of Health - Neurodegenerative Diseases Research Unit, National Institutes of Health - Computational Biology Core, National Institutes of Health - Computational Biology Core, National Institutes of Health, Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - Center for Alzheimer's and Related Dementias (CARD), Government of the United States of America - Center for Alzheimer's and Related Dementias (CARD), Johns Hopkins University - School of Medicine, Johns Hopkins University - Department of Pathology, National Institutes of Health - Neurodegenerative Diseases Research Unit, National Institutes of Health - Neurodegenerative Diseases Research Unit, National Institutes of Health - Neurodegenerative Diseases Research Unit, Uniformed Services University of the Health Sciences, United Kingdom Dementia Research Institute Centre, King’s College London - Maurice Wohl Clinical Neuroscience Institute, King’s College London - Maurice Wohl Clinical Neuroscience Institute, King’s College London - Department of Basic and Clinical Neuroscience, King’s College London - Department of Basic and Clinical Neuroscience, University of Milan - Department of Neurology and Laboratory of Neuroscience, University of Massachusetts Worcester - Department of Neurology, Fondazione IRCCS Istituto Neurologico ‘Carlo Besta’ - Unit of Genetics of Neurodegenerative and Metabolic Diseases, Macquarie University - Centre for MND Research, University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - School of Medical Sciences (SoMS), National Institutes of Health, Independent, Independent, Independent, Independent, University of Massachusetts Worcester - Department of Neurology, University of Massachusetts Worcester - Department of Neurology, University of Southampton - Faculty of Medicine, Health and Life Sciences, University of Sheffield - Sheffield Institute for Translational Neuroscience (SITraN), King’s College London - Maurice Wohl Clinical Neuroscience Institute, University of Massachusetts Worcester - Department of Neurology, ASO OIRM-S.Anna, University of Turin - Department of Neurosciences, Azienda Ospedaliera Universitaria Maggiore della Carità - ALS Center, Hebrew University of Jerusalem, King’s College London - Maurice Wohl Clinical Neuroscience Institute, University of Massachusetts Worcester - Department of Neurology, University of Massachusetts Worcester - Department of Neurology, Johns Hopkins University - Department of Pediatrics, King’s College London - Maurice Wohl Clinical Neuroscience Institute and University of Massachusetts Worcester - Department of Neurology
Downloads 36 (650,106)
Citation 3

Abstract:

Loading...

amyotrophic lateral sclerosis, genomics, de novo mutation, sphingolipid metabolism, SPTLC1, serine nutritional supplementation, deoxymethyl-sphinganine, individualized medicine